Greenberg Traurig’s Roman Fayerberg Speaks on BBA Intellectual Property Panel

Dec 15, 2022

Posted by Greenberg Traurig, LLP

BOSTON – Dec. 15, 2022 – Roman Fayerberg, Intellectual Property (IP) & Technology shareholder in global law firm Greenberg Traurig, LLP’s Boston office, spoke on the Boston Bar Association (BBA) panel, “IP Considerations for Medical Device Companies,” Dec. 13. Speakers discussed the intersectionality between Food and Drug Administration regulation and patent law, patent filing strategies for emerging medical technologies, and 510k submissions.

Fayerberg is a registered patent attorney with broad experience helping clients strategically protect and leverage their innovations globally. He works with clients to develop and manage worldwide patent portfolios and counsels clients regarding freedom to operate, patent landscape, and patent infringement and validity matters. Fayerberg also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities.

Fayerberg has represented clients ranging from startups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology. He understands the legal goals of each of his clients and develops and executes patent strategies that meet such goals.

A frequent speaker and author on topics related to patent law, Fayerberg has been recognized in IAM magazine’s IAM Patent 1000: The World’s Leading Patent Professionals. He previously served as a co-chair of the Boston Bar Association’s IP Section and as a co-chair of the Medical Device, Diagnostics & Digital Health Committee of the Massachusetts Biotechnology Council (MassBio).

About Greenberg Traurig’s Intellectual Property & Technology Practice: With more than 260 intellectual property attorneys and patent agents in the United States, Asia, and Europe, Greenberg Traurig provides a broad range of patent, trademark and copyright protection and strategic counseling. Greenberg Traurig was named a “National Tier 1” Law Firm for IP Litigation, Patent Law and Litigation, Copyright Law, Technology Law, and Information Technology Law by U.S. News and Best Lawyers, 2023 “Best Law Firms.” In addition, Greenberg Traurig was named a “Law Firm of the Year” for Trademark Law in the 2020 and 2022 editions of “Best Law Firms.” The BTI Consulting Group named Greenberg Traurig’s IP Litigation Practice a ‘Litigation Standout’ in the “BTI Litigation Outlook 2023: Litigation Spending in the Uncertain Economy and Beyond.”

About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to more than 80 attorneys practicing in the areas of bankruptcy and restructuring, corporate, emerging technology, energy, environmental, financial services, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, real estate, and tax. An important contributor to the firm’s international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of helping clients in complex legal matters and hands-on knowledge of the local business community, supported by the firm’s vast network of global resources.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2500 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm reported gross revenue of over $2 Billion for FY 2021 and is consistently among the top firms on the Am Law 100, Am Law Global 100, and NLJ 250. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 5.0 Certified Plus by The Diversity Lab and the Center for Resource Solutions Green-e® Energy program certifies that the firm’s U.S. offices are 100% powered by renewable energy. The firm is often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono. Web:

See all Member News